Riccardo Taulli
Orbassano, 10043, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Author Correction: Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion.
Journal: Nature genetics
Published: February 09, 2026
Unraveling lung cancer dynamics: a new metabolic signature improving the prediction of recurrence in resected lung adenocarcinoma.
Journal: Journal of translational medicine
Published: September 10, 2025
Shifting Shapes: The Endothelial-to-Mesenchymal Transition as a Driver for Cancer Progression.
Journal: International journal of molecular sciences
Published: June 03, 2025
From Cancer to Immune Organoids: Innovative Preclinical Models to Dissect the Crosstalk between Cancer Cells and the Tumor Microenvironment.
Journal: International journal of molecular sciences
Published: September 14, 2024
Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 03, 2023
Genetic Ablation of the MET Oncogene Defines a Crucial Role of the HGF/MET Axis in Cell-Autonomous Functions Driving Tumor Dissemination.
Journal: Cancers
Published: December 01, 2022
Tumor plasticity and therapeutic resistance in oncogene-addicted non-small cell lung cancer: from preclinical observations to clinical implications.
Journal: Critical reviews in oncology/hematology
Published: November 25, 2022
Correction to: Micro-RNA-215 and -375 regulate thymidylate synthase protein expression in pleural mesothelioma and mediate epithelial to mesenchymal transition.
Journal: Virchows Archiv : an international journal of pathology
Published: June 07, 2022
Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer Cells.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 13, 2022
MET Inhibition Sensitizes Rhabdomyosarcoma Cells to NOTCH Signaling Suppression.
Journal: Frontiers in oncology
Published: December 14, 2021
Last Updated: 09/26/2026